Evidence map›Paper›PMID 42668624›Full record

ArticleKidney medicine2026

Serial Donor-derived Cell-free DNA Monitoring in a Kidney Transplant Recipient With Adenovirus Nephritis.

Eric J Xu, Samir Hirpara, Akil S Kavcar, Natalia Jucha, Nimisha Sulejmani, Martha Pavlakis, Seymour Rosen, Aditya S Pawar

Abstract readCase Reports
In one paragraph

Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eric J XuDivision of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA.
Samir HirparaDivision of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA.
Akil S KavcarDivision of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA.
Natalia JuchaMedical Affairs, CareDx, Brisbane, CA.
Nimisha SulejmaniMedical Affairs, CareDx, Brisbane, CA.
Martha PavlakisDivision of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA.
Seymour RosenDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, MA.
Aditya S PawarDivision of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opportunistic infection is one of the most common complications in solid organ transplantation. In particular, viral infections of the renal allograft pose a diagnostic and management dilemma because the histopathologic differences between viral allograft nephritis and acute rejection can be subtle yet critical to recognize, given the fundamentally contradictory treatment strategies. Although noninvasive tests, such as viral polymerase chain reaction, can aid in the diagnosis of viral allograft involvement, a definitive diagnosis requires a kidney biopsy. Donor-derived cell-free DNA (dd-cfDNA) has been validated for detecting both acute cellular rejection and antibody-mediated rejection, but its utility as a test for renal allograft infection remains to be defined and has largely been restricted to cases of BK polyomavirus nephropathy. Here, we described a case of acute kidney injury that developed shortly after kidney transplantation. dd-cfDNA was elevated, and biopsy revealed findings characteristic of adenovirus infection. We examined the differential diagnosis of viral infections in renal allografts and explored the role of dd-cfDNA in managing these cases.

Identifiers

PMID42668624
PMCPMC13524705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.